Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis

  1. Hungria, V.
  2. Martínez-Baños, D.M.
  3. Mateos, M.-V.
  4. Dimopoulos, M.A.
  5. Cavo, M.
  6. Heeg, B.
  7. Garcia, A.
  8. Lam, A.
  9. Machnicki, G.
  10. He, J.
  11. Fernandez, M.
Aldizkaria:
Advances in Therapy

ISSN: 1865-8652,  0741-238X

Argitalpen urtea: 2020

Alea: 37

Zenbakia: 12

Orrialdeak: 4996-5009

Mota: Artikulua

DOI: 10.1007/S12325-020-01521-9 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus